Clinical Value of Hybrid TOF-PET/MR Imaging–Based Multiparametric Imaging in Localizing Seizure Focus in Patients with MRI-Negative Temporal Lobe Epilepsy

References

1. 1.↵
   2. Duncan JS,
   3. Winston GP,
   4. Koepp MJ, et al

   . Brain imaging in the assessment for epilepsy surgery. Lancet Neurol 2016;15:420–33 doi:10.1016/S1474-4422(15)00383-X pmid:26925532

   CrossRefPubMed
2. 2.↵
   2. Engel J Jr.,
   3. McDermott MP,
   4. Wiebe S, et al

   ; Early Randomized Surgical Epilepsy Trial (ERSET) Study Group. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA 2012;307:922–30 doi:10.1001/jama.2012.220 pmid:22396514

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Capraz IY,
   3. Kurt G,
   4. Akdemir Ö, et al

   . Surgical outcome in patients with MRI-negative, PET-positive temporal lobe epilepsy. Seizure 2015;29:63–68 doi:10.1016/j.seizure.2015.03.015 pmid:26076845

   CrossRefPubMed
4. 4.↵
   2. Tan YL,
   3. Kim H,
   4. Lee S, et al

   . Quantitative surface analysis of combined MRI and PET enhances detection of focal cortical dysplasias. Neuroimage 2018;166:10–18 doi:10.1016/j.neuroimage.2017.10.065 pmid:29097316

   CrossRefPubMed
5. 5.↵
   2. Blümcke I,
   3. Thom M,
   4. Aronica E, et al

   . The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011;52:158–74 doi:10.1111/j.1528-1167.2010.02777.x pmid:21219302

   CrossRefPubMed
6. 6.↵
   2. Setoain X,
   3. Carreño M,
   4. Pavía J, et al

   . PET and SPECT in epilepsy [in Spanish]. Rev Esp Med Nucl Imagen Mol 2014;33:165–74 doi:10.1016/j.remn.2014.01.001 pmid:24565567

   CrossRefPubMed
7. 7.↵
   2. Schwartz TH

   . Neurovascular coupling and epilepsy: hemodynamic markers for localizing and predicting seizure onset. Epilepsy Curr 2007;7:91–94 doi:10.1111/j.1535-7511.2007.00183.x pmid:17694162

   CrossRefPubMed
8. 8.↵
   2. Won HJ,
   3. Chang KH,
   4. Cheon JE, et al

   . Comparison of MR imaging with PET and ictal SPECT in 118 patients with intractable epilepsy. AJNR Am J Neuroradiol 1999;20:593–99 pmid:10319968

   Abstract/FREE Full Text
9. 9.↵
   2. Chassoux F,
   3. Rodrigo S,
   4. Semah F, et al

   . FDG-PET improves surgical outcome in negative MRI Taylor-type focal cortical dysplasias. Neurology 2010;75:2168–75 doi:10.1212/WNL.0b013e31820203a9 pmid:21172840

   CrossRefPubMed
10. 10.↵
    2. Kumar A,
    3. Chugani HT

    . The role of radionuclide imaging in epilepsy, Part 1: sporadic temporal and extratemporal lobe epilepsy. J Nucl Med Technol 2017;45:14–21 doi:10.2967/jnumed.112.114397 pmid:23970368

    Abstract/FREE Full Text
11. 11.↵
    2. Uijl SG,
    3. Leijten FS,
    4. Arends JB, et al

    . The added value of [18F]-fluoro-D-deoxyglucose positron emission tomography in screening for temporal lobe epilepsy surgery. Epilepsia 2007;48:2121–29 doi:10.1111/j.1528-1167.2007.01197.x pmid:17651417

    CrossRefPubMed
12. 12.↵
    2. Yang PF,
    3. Pei JS,
    4. Zhang HJ, et al

    . Long-term epilepsy surgery outcomes in patients with PET-positive, MRI-negative temporal lobe epilepsy. Epilepsy Behav 2014;41:91–97 doi:10.1016/j.yebeh.2014.09.054 pmid:25461196

    CrossRefPubMed
13. 13.↵
    2. LoPinto-Khoury C,
    3. Sperling MR,
    4. Skidmore C, et al

    . Surgical outcome in PET-positive, MRI-negative patients with temporal lobe epilepsy. Epilepsia 2012;53:342–48 doi:10.1111/j.1528-1167.2011.03359.x pmid:22192050

    CrossRefPubMed
14. 14.↵
    2. Oishi M,
    3. Ishida G,
    4. Morii K, et al

    . Ictal focal hyperperfusion demonstrated by arterial spin-labeling perfusion MRI in partial epilepsy status. Neuroradiology 2012;54:653–56 doi:10.1007/s00234-012-1027-7 pmid:22418862

    CrossRefPubMed
15. 15.↵
    2. Boscolo Galazzo I,
    3. Storti SF,
    4. Del Felice A, et al

    . Patient-specific detection of cerebral blood flow alterations as assessed by arterial spin labeling in drug-resistant epileptic patients. PLoS One 2015;10:e0123975 doi:10.1371/journal.pone.0123975 pmid:25946055

    CrossRefPubMed
16. 16.↵
    2. Kim BS,
    3. Lee ST,
    4. Yun TJ, et al

    . Capability of arterial spin labeling MR imaging in localizing seizure focus in clinical seizure activity. Eur J Radiol 2016;85:1295–303 doi:10.1016/j.ejrad.2016.04.015 pmid:27235877

    CrossRefPubMed
17. 17.↵
    2. Sierra-Marcos A,
    3. Carreño M,
    4. Setoain X, et al

    . Accuracy of arterial spin labeling magnetic resonance imaging (MRI) perfusion in detecting the epileptogenic zone in patients with drug-resistant neocortical epilepsy: comparison with electrophysiological data, structural MRI, SISCOM and FDG-PET. Eur J Neurol 2016;23:160–67 doi:10.1111/ene.12826 pmid:26346555

    CrossRefPubMed
18. 18.↵
    2. Garibotto V,
    3. Heinzer S,
    4. Vulliemoz S, et al

    . Clinical applications of hybrid PET/MRI in neuroimaging. Clin Nucl Med 2013;38:e13–18 doi:10.1097/RLU.0b013e3182638ea6 pmid:23242058

    CrossRefPubMed
19. 19.↵
    2. Schwenzer NF,
    3. Stegger L,
    4. Bisdas S, et al

    . Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients: current state of image quality. Eur J Radiol 2012;81:3472–78 doi:10.1016/j.ejrad.2011.12.027 pmid:22260898

    CrossRefPubMed
20. 20.↵
    2. Ding YS,
    3. Chen BB,
    4. Glielmi C, et al

    . A pilot study in epilepsy patients using simultaneous PET/MR. Am J Nucl Med Mol Imaging 2014;4:459–70 pmid:25143864

    PubMed
21. 21.↵
    2. Shin HW,
    3. Jewells V,
    4. Sheikh A, et al

    . Initial experience in hybrid PET-MRI for evaluation of refractory focal onset epilepsy. Seizure 2015;31:1–4 doi:10.1016/j.seizure.2015.06.010 pmid:26362368

    CrossRefPubMed
22. 22.↵
    2. Boscolo Galazzo I,
    3. Mattoli MV,
    4. Pizzini FB, et al

    . Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling. Neuroimage Clin 2016;11:648–57 doi:10.1016/j.nicl.2016.04.005 pmid:27222796

    CrossRefPubMed
23. 23.↵
    2. Noe K,
    3. Sulc V,
    4. Wong-Kisiel L, et al

    . Long-term outcomes after nonlesional extratemporal lobe epilepsy surgery. JAMA Neurol 2013;70:1003–08 doi:10.1001/jamaneurol.2013.209 pmid:23732844

    CrossRefPubMed
24. 24.↵
    2. Wang DD,
    3. Piao YS,
    4. Blumcke I, et al

    . A distinct clinicopathological variant of focal cortical dysplasia IIId characterized by loss of layer 4 in the occipital lobe in 12 children with remote hypoxic-ischemic injury. Epilepsia 2017;58:1697–1705 doi:10.1111/epi.13855 pmid:28833053

    CrossRefPubMed
25. 25.↵
    2. Gaillard WD,
    3. Berl MM,
    4. Duke ES, et al

    . fMRI language dominance and FDG-PET hypometabolism. Neurology 2011;76:1322–29 doi:10.1212/WNL.0b013e31821527b5 pmid:21368285

    Abstract/FREE Full Text
26. 26.↵
    2. Lee JJ,
    3. Lee SK,
    4. Lee SY, et al

    . Frontal lobe epilepsy: clinical characteristics, surgical outcomes and diagnostic modalities. Seizure 2008;17:514–23 doi:10.1016/j.seizure.2008.01.007 pmid:18329907

    CrossRefPubMed
27. 27.↵
    2. Archambaud F,
    3. Bouilleret V,
    4. Hertz-Pannier L, et al

    . Optimizing statistical parametric mapping analysis of 18F-FDG PET in children. EJNMMI Res 2013;3:2 doi:10.1186/2191-219X-3-2 pmid:23289862

    CrossRefPubMed
28. 28.↵
    2. Zhu Y,
    3. Feng J,
    4. Wu S, et al

    . Glucose metabolic profile by visual assessment combined with statistical parametric mapping analysis in pediatric patients with epilepsy. J Nucl Med 2017;58:1293–99 doi:10.2967/jnumed.116.187492 pmid:28104740

    Abstract/FREE Full Text
29. 29.↵
    2. Lee KK,
    3. Salamon N

    . [18F] fluorodeoxyglucose-positron-emission tomography and MR imaging coregistration for presurgical evaluation of medically refractory epilepsy. AJNR Am J Neuroradiol 2009;30:1811–16 doi:10.3174/ajnr.A1637 pmid:19628624

    Abstract/FREE Full Text
30. 30.↵
    2. Rheims S,
    3. Jung J,
    4. Ryvlin P

    . Combination of PET and magnetoencephalography in the presurgical assessment of MRI-negative epilepsy. Front Neurol 2013;4:188 doi:10.3389/fneur.2013.00188 pmid:24312076

    CrossRefPubMed
31. 31.↵
    2. Lim YM,
    3. Cho YW,
    4. Shamim S, et al

    . Usefulness of pulsed arterial spin labeling MR imaging in mesial temporal lobe epilepsy. Epilepsy Res 2008;82:183–89 doi:10.1016/j.eplepsyres.2008.08.001 pmid:19041041

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Blauwblomme T,
    3. Boddaert N,
    4. Chémaly N, et al

    . Arterial spin labeling MRI: a step forward in non-invasive delineation of focal cortical dysplasia in children. Epilepsy Res 2014;108:1932–39 doi:10.1016/j.eplepsyres.2014.09.029 pmid:25454505

    CrossRefPubMed
33. 33.↵
    2. Haller S,
    3. Zaharchuk G,
    4. Thomas DL, et al

    . Arterial spin labeling perfusion of the brain: emerging clinical applications. Radiology 2016;281:337–56 doi:10.1148/radiol.2016150789 pmid:27755938

    CrossRefPubMed
34. 34.↵
    2. Deibler AR,
    3. Pollock JM,
    4. Kraft RA, et al

    . Arterial spin-labeling in routine clinical practice, Part 2: hypoperfusion patterns. AJNR Am J Neuroradiol 2008;29:1235–41 doi:10.3174/ajnr.A1033 pmid:18356467

    Abstract/FREE Full Text
35. 35.↵
    2. Pendse N,
    3. Wissmeyer M,
    4. Altrichter S, et al

    . Interictal arterial spin-labeling MRI perfusion in intractable epilepsy. J Neuroradiol 2010;37:60–63 doi:10.1016/j.neurad.2009.05.006 pmid:19674791

    CrossRefPubMed
36. 36.↵
    2. Storti SF,
    3. Boscolo Galazzo I,
    4. Del Felice A, et al

    . Combining ESI, ASL and PET for quantitative assessment of drug-resistant focal epilepsy. Neuroimage 2014;102(Pt 1):49–59 doi:10.1016/j.neuroimage.2013.06.028 pmid:23792219

    CrossRefPubMed
37. 37.↵
    2. Lascano AM,
    3. Perneger T,
    4. Vulliemoz S, et al

    . Yield of MRI, high-density electric source imaging (HD-ESI), SPECT and PET in epilepsy surgery candidates. Clin Neurophysiol 2016;127:150–55 doi:10.1016/j.clinph.2015.03.025 pmid:26021550

    CrossRefPubMed
38. 38.↵
    2. Shaffer JL,
    3. Petrella JR,
    4. Sheldon FC, et al

    ; Alzheimer's Disease Neuroimaging Initiative. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 2013;266:583–91 doi:10.1148/radiol.12120010 pmid:23232293

    CrossRefPubMedWeb of Science
39. 39.↵
    2. Fernández S,
    3. Donaire A,
    4. Serès E, et al

    . PET/MRI and PET/MRI/SISCOM coregistration in the presurgical evaluation of refractory focal epilepsy. Epilepsy Res 2015;111:1–9 doi:10.1016/j.eplepsyres.2014.12.011 pmid:25769367

    CrossRefPubMed
40. 40.↵
    2. Chen G,
    3. Lei D,
    4. Ren J, et al

    . Patterns of postictal cerebral perfusion in idiopathic generalized epilepsy: a multi-delay multi-parametric arterial spin labelling perfusion MRI study. Sci Rep 2016;6:28867 doi:10.1038/srep28867 pmid:27374369

    CrossRefPubMed
41. 41.↵
    2. Van Bogaert P,
    3. Massager N,
    4. Tugendhaft P, et al

    . Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy. Neuroimage 2000;12:129–38 doi:10.1006/nimg.2000.0606 pmid:10913319

    CrossRefPubMedWeb of Science
42. 42.↵
    2. Pizzini FB,
    3. Farace P,
    4. Manganotti P, et al

    . Cerebral perfusion alterations in epileptic patients during peri-ictal and post-ictalphase: PASL vs DSC-MRI. Magn Reson Imaging 2013;31:1001–05 doi:10.1016/j.mri.2013.03.023 pmid:23623332

    CrossRefPubMed
43. 43.↵
    2. So EL,
    3. Ryvlin P

    . MRI-Negative Epilepsy: Evaluation and Surgical Management. Cambridge: Cambridge University Press, 2015